CA2602336A1 — Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
Assigned to UCB SA · Expires 2006-10-05 · 20y expired
What this patent protects
The present invention relates to compounds comprising an oxazole or thiazole moiety of formula (I), processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as H3 -receptor ligands, Formula (I), wherein , A1 is CH, C(alkyl), C-halogen or …
USPTO Abstract
The present invention relates to compounds comprising an oxazole or thiazole moiety of formula (I), processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as H3 -receptor ligands, Formula (I), wherein , A1 is CH, C(alkyl), C-halogen or N; Rl is hydrogen, halogen, C1-6 alkyl or alkoxy; R2 is, Formula (II~), A3 is O or S; R3 is hydrogen, halogen, C1-6 alkyl or alkoxy; R4 is hydrogen, halogen, C1-6 alkyl, alkoxy or -O-L; R5 is hydrogen or -O-L, wherein L is an aminoalkyl group and at least one of R4 and R5 should be -O-L.
Drugs covered by this patent
- Klisyri (TIRBANIBULIN) · Almirall
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.